Full View

Targeting prolactin receptor (PRLR) signaling in PRLR-positive breast and prostate cancer

CC O'Sullivan, SE Bates - The oncologist, 2016 - academic.oup.com
In this issue of The Oncologist, Agarwal et al. report negative results from a phase I trial of
LFA102. Although “negative” in terms of antitumor activity, the study provides useful …
被引用次数：31 相关文章

Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer.

CC O'Sullivan, SE Bates - The Oncologist, 2016 - europepmc.org
In this issue of The Oncologist, Agarwal et al. report negative results from a phase I trial of
LFA102. Although “negative” in terms of antitumor activity, the study provides useful …
[HTML] nih.gov

[HTML][HTML] Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer

CC O'Sullivan, SE Bates - The Oncologist, 2016 - ncbi.nlm.nih.gov
In this issue of The Oncologist, Agarwal et al. report negative results from a phase I trial of
LFA102. Although “negative” in terms of antitumor activity, the study provides useful …
[PDF] wiley.com

[PDF][PDF] Targeting Prolactin Receptor (PRLR) Signaling in PRLR‐Positive Breast and Prostate Cancer

CC O'Sullivan, SE Bates - The Oncologist, 2016 - Wiley Online Library
In this issue of The Oncologist, Agarwal et al. report negative results from a phase I trial of
LFA102. Although “negative” in terms of antitumor activity, the study provides useful …

Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer

CC O'Sullivan, SE Bates - The oncologist, 2016 - pubmed.ncbi.nlm.nih.gov
In this issue of The Oncologist, Agarwal et al. report negative results from a phase I trial of
LFA102. Although “negative” in terms of antitumor activity, the study provides useful …